The influence of hepatic function on prostate cancer outcomes after radical prostatectomy

Prostate Cancer and Prostatic Diseases

Volumn 13, Issue 2, 2010, Pages 173-177

  Banez L L ^a   Loftis, R M ^b   Freedland, S J ^a   Presti Jr , J C ^c   Aronson, W J ^d   Amling, C L ^e   Kane, C J ^f   Terris, M K ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f Rady Children's Specialists of San Diego   (United States)

Author keywords

Liver function tests; Pathology; Prostate neoplasm; PSA recurrence; Radical prostatectomy; Staging

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA BASE; DISEASE SEVERITY; GLEASON SCORE; HUMAN; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER FUNCTION TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK; TREATMENT OUTCOME;

EID: 77952541522     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2010.3     Document Type: Article

References (24)

1. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 1996;88:1118-1126.
2. Severi G, Morris HA, MacInnis RJ, English DR, Tilley W, Hopper JL et al. Circulating steroid hormones and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006;15:86-91.
3. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215-224.
4. Bañez LL, Hamilton RJ, Partin AW, Vollmer RT, Sun L, Rodriguez C et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007;298:2275-2280. (Pubitemid 350146217)
5. Freedland SJ, Platz EA, Presti Jr JC, Aronson WJ, Amling CL, Kane CJ et al. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol 2006;175:500-504.
6. Presti Jr JC, Lee U, Brooks JD, Terris MK. Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population. J Urol 2004;171:2199-2202.
7. Maruyama Y, Adachi Y, Aoki N, Suzuki Y, Shinohara H, Yamamoto T. Mechanism of feminization in male patients with non-alcoholic liver cirrhosis: role of sex hormone-binding globulin. Gastroenterol Jpn 1991;26:435-439.
8. Luppa PB, Thaler M, Schulte-Frohlinde E, Schreiegg A, Huber U, Metzger J. Unchanged androgen-binding properties of sex hormone-binding globulin in male patients with liver cirrhosis. Clin Chem Lab Med 2006;44:967-973.
9. Lindholm J, Fabricius-Bjerre N, Bahnsen M, Boiesen P, Hagen C, Christensen T. Sex steroids and sex-hormone binding globulin in males with chronic alcoholism. Eur J Clin Invest 1978;8:273-276.
10. Wang YJ, Wu JC, Lee SD, Tsai YT, Lo KJ. Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men. Hepatogastroenterology 1991;38:531-534.
11. Dennis LK. Meta-analysis for combining relative risks of alcohol consumption and prostate cancer. Prostate 2000;42:56-66.
12. Breslow RA, Weed DL. Review of epidemiologic studies of alcohol and prostate cancer: 1971-1996. Nutr Cancer 1998;30:1-13.
13. Sesso HD, Paffenbarger Jr RS, Lee IM. Alcohol consumption and risk of prostate cancer: the harvard alumni health study. Int J Epidemiol 2001;30:749-755.
14. Platz EA, Leitzmann MF, Rimm EB, Willett WC, Giovannucci E. Alcohol intake, drinking patterns, and risk of prostate cancer in a large prospective cohort study. Am J Epidemiol 2004;159:444-453.
15. Albertsen K, Gronbaek M. Does amount or type of alcohol influence the risk of prostate cancer? Prostate 2002;52:297-304.
16. Breslow RA, Wideroff L, Graubard BI, Erwin D, Reichman ME, Ziegler RG et al. Alcohol and prostate cancer in the NHANES I epidemiologic follow-up study. First national health and nutrition examination survey of the united states. Ann Epidemiol 1999;9:254-261.
17. Barba M, McCann SE, Schunemann HJ, Stranges S, Fuhrman B, De Placido S et al. Lifetime total and beverage specific-alcohol intake and prostate cancer risk: a case-control study. Nutr J 2004;3:23.
18. Schatzl G, Madersbacher S, Thurridl T, Waldmuller J, Kramer G, Haitel A et al. High-grade prostate cancer is associated with low serum testosterone levels. Prostate 2001;47:52-58.
19. Lucia MS, Epstein JI, Goodman PJ, Darke AK, Reuter VE, Civantos F et al. Finasteride and high-grade prostate cancer in the prostate cancer prevention trial. J Natl Cancer Inst 2007;99:1375-1383.
20. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
21. Akdogan M, Hassoun BS, Gurakar A, El-Sahwi K, Jazzar A, Wright H et al. Prostate-specific antigen levels among cirrhotic patients. Int J Biol Markers 2002;17:161-164.
22. Kubota Y, Sasagawa I, Sinzawa H, Kunii T, Itoh K, Miura H et al. Serum levels of free and total prostate-specific antigen in males with liver cirrhosis. Eur Urol 1999;36:409-412.
23. Cetinkaya M, Cetinkaya H, Ulusoy E, Baz S, Memis A, Yasa H et al. Effect of postnecrotic and alcoholic hepatic cirrhosis on development of benign prostatic hyperplasia. Prostate 1998;36:80-84.
24. Velicer CM, Kristal A, White E. Alcohol use and the risk of prostate cancer: results from the VITAL cohort study. Nutr Cancer 2006;56:50-56. (Pubitemid 46173413)